Probiotics vs activated charcoal for itching in kidney disease
Treatments studied
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether probiotics or activated charcoal can help reduce itching (uremic pruritus) in people with chronic kidney disease who are not on dialysis. You will be randomly assigned to one of the two treatments to see which works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have chronic kidney disease and experience itching (uremic pruritus)
- You must not be on dialysis
- Your itching must not be caused by other skin conditions like psoriasis or eczema
- You must not be allergic to activated charcoal or probiotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called nalfurafine to see if it can reduce severe itching that many people on dialysis have. It will compare the medicine to standard care to find out if it works.
This study tests whether hand massage can help reduce the chronic itching that many people on dialysis experience. It compares two groups to see if massage provides relief and improves quality of life.
This trial tests a new tablet called nalfurafine to help reduce severe itching that happens in people on regular kidney dialysis. If you've had itching for a while despite trying other treatments, this study may help you and contribute to better options for dialysis patients.
This trial studies an oral product (a “uremic toxin” absorber) plus probiotics to help slow the progression of chronic kidney disease. It may help by lowering harmful gut-related substances that can build up when kidney function is reduced.
This trial tests if taking activated charcoal by mouth can help people with advanced kidney disease who are already on dialysis. It may improve how the body handles certain waste products and reduce the need for other medicines.
This trial tests if an oral medication that absorbs toxins plus probiotics can reduce inflammation and slow kidney damage in people with diabetes-related kidney disease (DKD). It may help those with mild to severe kidney function loss.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.